Effect of S-ethylisothiourea, a putative inhibitor of inducible nitric oxide synthase, on mouse skin vascular permeability

Japanese Journal of Pharmacology

Volumn 70, Issue 3, 1996, Pages 269-271

  Muraki, Takamura ^a   Fujii, Emiko ^a   Okada, Midori ^a   Horikawa, Hiroaki ^a   Irie, Kaoru ^a   Ohba, Ken Ichi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Inducible nitric oxide synthase; Lipopolysaccharide; Vascular permeability

Indexed keywords

AMINOGUANIDINE; DIPHENHYDRAMINE; ENZYME INHIBITOR; INDOMETACIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; S ETHYLISOTHIOUREA; SEROTONIN; THIOUREA DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG SPECIFICITY; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; SKIN BLOOD VESSEL;

EID: 0029970467     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.70.269     Document Type: Article

References (15)

1. Ignarro LJ: Endothelium-derived nitric oxide: actions and properties. FASEB J 3, 31-36 (1989)
2. Schmidt HHHW and Walter U: NO at work. Cell 78, 919-925 (1994)
3. Knowles RG and Moncada S: Nitric oxide synthase in mammals. Biochem J 298, 249-258 (1994)
4. Thiemermann C: Role of the l-arginine-nitric oxide pathway in circulatory shock. Adv Pharmacol 28, 45-79 (1994)
5. Fukuto JM and Chaudhuri G: Inhibition of constitutive and iaducible nitric oxide synthase: Potential selective inhibition. Annu Rev Pharmacol Toxicol 35, 165-194 (1995)
6. Griffiths MJD, Messent M, MacAllister RJ and Evans TW: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 110, 963-968 (1993)
7. Fujii E, Irie K, Uchida Y, Tsukahara F and Muraki T: Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn Schmiedebergs Arch Pharmacol 350, 361-364 (1994)
8. Fujii E, Irie K, Uchida Y, Ohba K and Muraki T: Role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin. Eur J Pharmacol 273, 267-272 (1995)
9. Fujii E, Irie K and Muraki T: Nitric oxide plays a role of increase in vascular permeability induced by 5-hydroxytryptamine (5-HT), substance P, bradykinin and endotoxin (LPS) but not by platelet-activating factor (PAF) and histamine in mouse skin. Jpn J Pharmacol 67, Supp I, 290P (1995)
10. Fujii E, Irie K, Ogawa A, Ohba K and Muraki T: Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur J Pharmacol (in press)
11. Garvey EP, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Harmon MF, Paith JE and Furfine ES: Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino-acid isothioureas. J Biol Chem 269, 26669-26676 (1994)
12. Nakane M, Klinghofer V, Kuk JE, Donnelly JL, Budzik GP, Pollock JS, Basha F and Carter GW: Novel potent and selective inhibitors of inducible nitric oxide synthase. Mol Pharmacol 47, 831-834 (1995)
13. Szabó C, Southan GJ and Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with Smethylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91, 12472-12476 (1994)
14. Southan GJ, Szabó C and Thiemermann C: Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 114, 510-516 (1995)
15. Zuany-Amorim C, Corfeiro RSB and Vargaftig BB: Involvement of leukotrienes in allergic inflammation in mice. Eur J Pharmacol 257, 211 -216 (1994)